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Definitive Hematopoietic Stem Cells
in the AGM and Liver of the Mouse Embryo
Maria´-Jose´ Sa´nchez,* Alan Holmes, Colin Miles, et al., 1992; Berenson et al., 1988, 1991) has been devel-
oped. LTR-HSCs can be obtained from the CD341 sub-and Elaine Dzierzak†
set of mouse bone marrow (Krause et al., 1994). Al-National Institute for Medical Research
though not as extensively studied, other markers onThe Ridgeway, Mill Hill
bone marrow HSCs include AA4.1 (Szilvassy and Cory,London, NW7 1AA
1993; Orlic et al., 1993), ER-MP12 (van der Loo et al.,United Kingdom
1995; Slieker et al., 1993), CD4 (Wineman et al., 1992;
Onishi et al., 1993), and class I histocompatibility anti-
gens (Szilvassy et al., 1989).
Summary Generally, thesesame cell surface markers also define
fetal liver LTR-HSCs (Zeigler et al., 1994; Jordan et al.,
At day 10 in mouse gestation, the intraembryonic 1995). However, some phenotypic features unique to
aorta–gonads–mesonephros (AGM) region generates fetal liver LTR-HSCs have been revealed: first, 13 and
the first definitive hematopoietic stem cells (HSCs) of 14 days postcoitum (dpc) fetal liver cells are Mac-11
the adult blood system. By 11 days postcoitum, the (Morrison et al., 1995), whereas bone marrow LTR-HSCs
liver contains such HSCs. While HSCs of the adult are Mac-12; second, antigens AA4.1 (Jordan et al., 1990;
bone marrow and late-stage fetal liver have been ex- Jordan and Lemischka, 1990) and CD45RB (Rebel et al.,
tensively characterized for cell surface markers, there 1996) are expressed in fetal liver population enriched
has been no phenotypic description of the first HSCs for HSCs, whereas HSC activity is reported in both
during embryo development. We report here the tem- AA4.11 and AA4.12 adult bone marrow populations (Szil-
poral cell surface phenotype of HSCs from the AGM vassy and Cory, 1993; Orlic at al., 1993; Trevisan and
region and early fetal liver and show that all HSCs Iscove, 1995; Rebel et al., 1996).
reside in the c-kit1 population. c-kit1 HSCs from AGM The predominant hematopoietic organs in the pre-
and liver are mainly CD341 and in the AGM are in both liver hematopoieticstage of mouse development (begin-
Mac-11 and Mac-12 fractions. These results demon- ning at 7.5 dpc) are the embryonic yolk sac (YS) (Russel
strate that during mouse ontogeny the first definitive and Bernstein, 1966; Moore and Metcalf, 1970), para-
HSCs are similar in cell surface phenotype to the HSCs aortic splanchnopleura (Godin et al., 1993; Dieterlen-
of adult bone marrow but that spatial localization and Lie`vre and Le Douarin, 1993) and the aorta–gonads–
developmental time are critical factors in the pheno- mesonephros (AGM) region (Medvinsky et al., 1993;
typic assessment of this functional cell population. Medvinsky, 1993; Mu¨ller et al., 1994; Dzierzak and Med-
vinsky, 1995). From 8–9 dpc, the extraembryonic YS as
well as the intraembryonic para-aortic splanchnopleuraIntroduction
contain AA4.11 progenitor cells capable of differentiat-
ing into both the myeloid and lymphoid lineages (Godin
Long-term repopulating hematopoietic stem cells (LTR-
et al., 1995). However, HSCs capable of long-term re-
HSCs) of the adult mouse bone marrow have been
population of the entire adult hematopoietic system are
extensively characterized for cell surface phenotype.
generated and detected only beginning at 10 dpc in the
Although there are no monoclonal antibodies (MAbs) intraembryonic AGM region (Mu¨ller et al., 1994; Medvin-
available that exclusively recognize LTR-HSCs, these sky and Dzierzak, 1996). By 11 dpc, LTR-HSC activity
rare cells have been enriched by fluorescence-activated is found in the YS and liver, as well as the AGM region.
cell sorting (FACS) procedures utilizing antibodies spe- Phenotypic characterization of LTR-HSCs from 11 dpc
cific for various cell surface antigens. The combination YS show that at least some of them express the AA4.1
of Sca-1 (Spangrude et al., 1988) and Thy-1 (Mu¨ller- antigen, but no YS cells express significant levels of
Sieburg et al., 1986) antigen expression and the absence Sca-1, CD44, or CD4 antigens (Huang and Auerbach,
or low expression of mature hematopoietic lineage 1993). Descriptive analyses of 8–8.5 dpc YS, 10 dpc
markers (Linlo/2) allows significant enrichment of bone liver, and 11 dpc thymus show the expression of c-kit
marrow LTR-HSCs (Uchida and Weissman, 1992). The on some cells within these tissues (Ogawa et al., 1993;
c-kit antigen in combination with Sca-11/Thy-1lo/Lin2 Palacios and Nishikawa, 1992); more specifically, eryth-
phenotype yields further enrichment (Okada et al., 1991; rocytes and mast cells, but also neural crest–derived
Ikuta and Weissman, 1992). More recently, an antibody cells and primordial germ cells, express c-kit (Matsui et
against the murine sialomucin CD34 protein (one of the al., 1990; Keshet et al., 1991). In functional studies, the
most commonly used molecules for human progenitor c-kit-mediated enrichment of BFU-Es and CFU-GMs
and stem cell enrichment) (Katz et al., 1985; Andrews from 9 dpc YS cells demonstrates the expression of this
protein on the surface of early committed progenitor
cells (Ogawa et al., 1993). However, c-kit-mediated en-
*Present address: Cambridge University, Department of Hematol- richment of LTR-HSC activity from the early mouse con-
ogy, MRC Center, Hills Road, Cambridge, CB2 2QH, United
ceptus has not been demonstrated. Similarly, studiesKingdom.
of CD34 expression in whole-mount mouse embryos†Present address: Erasmus University, Medical Faculty, Depart-
show CD34 on the surface of YS hematopoietic cells atment of Cell Biology and Genetics, 3000 DR Rotterdam, The Nether-
lands. 7.5 and 9.5 dpc and the para-aortic region and liver
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at 13 dpc (Young et al., 1995), but no transplantation reconstituting activity resides only in the c-kit1 popula-
tion. A mean of 6.6 6 4.5 3 103 c-kit1 cells from AGMexperiments demonstrating LTR-HSC function of these
populations have been performed. Complementary de- yielded 12 out of 20 reconstituted recipients. However,
10-fold more cells or a mean of 63 6 32 3 103 c-kit1scriptive experiments in human embryo cross-sections
have shown a similar expression pattern for CD34 on liver cells is needed to get similar reconstitution in 7 out
of 13 recipients.hematopoietic cells associated with the aorta (Tavian
et al., 1996). While these studies suggest that the embry- To determine whether this high level repopulation was
multilineage, we examined 14 long-term transplantedonic hematopoietic cells bear markers comparable with
those expressed on definitive LTR-HSCs of the adult recipients that received AGM c-kit1 cells and 13 recipi-
ents that received liver c-kit1 cells. Hematopoietic tis-bone marrow and 14 dpc fetal liver, only antibody stain-
ing and flow cytometric sorting in combination with test- sues (blood, thymus, spleen, lymph nodes, and bone
marrow) and purified B cells and macrophages wereing for the long-term, pluripotential hematopoietic prop-
erties of these cells after transplantation into lethally assayed by PCR analysis for the presence of the LacZ
transgene. As shown in Table 2, all 14 AGM recipientsirradiated mice can unequivocally indicate the expres-
sion of these markers on the firstLTR-HSCs in themouse maintained the same level of repopulation in peripheral
blood after 6–10 months. In 6 of 12 animals that showedembryo.
Thus, we have performed such sorting and trans- 100% donor-derived peripheral blood, all the hemato-
poietic tissues, B cells, and macrophages were 100%plantation experiments and report here the phenotypic
characterization of the first functional LTR-HSCs in the positive. The other animals showed some small variation
in the level of repopulation in the individual tissues andAGM region and the early fetal liver. We show that AGM
region and early fetal liver LTR-HSCs are very similar to lineages. Recipients reconstituted with liver c-kit1 cells
did not show the same stability in repopulation as thethe definitive LTR-HSCs of the adult and are detected
within the c-kit1 population. More extensive phenotypic AGM recipients; 3 of 9 recipients decreased peripheral
blood signal from 100% to 10%. Two recipients with ancharacterization of these cells within the mouse embryo
demonstrates that quantitative or qualitative changes initial 10% reconstitution completely lost donor signal
in blood after 6 months, although one individual is 1%–(or both) in LTR-HSCs occur within the c-kit1 population
and vary according to localization and organism devel- 10% positive in bone marrow and macrophages and the
other is 1%–10% positive in B cells and macrophages.opmental time.
These data show that all LTR-HSCs in the AGM and
liver are within the c-kit1 fraction, that these cells can
Results yield complete multilineage repopulation, and that the
reconstitution potential of the c-kit1 liver population is
LTR-HSCs from 11 dpc AGM and Liver more restricted than that of the AGM.
Are Surface c-kit1
To determine the cell surface phenotype of the first
LTR-HSCs within the developing mouse embryo, we Temporal Analysis of LTR-HSC Potential
of c-kit1 Cellsexamined cells from the AGM region and early fetal liver
for expression of the c-kit cell surface marker. Cells Since the hematopoietic system of the early- and mid-
gestation embryo is rapidly expanding and differentiat-were obtained from pooled AGM regions and livers of
11 dpc (Ly-6E.1–LacZ) transgenic mouse embryos and ing, c-kit expression was analyzed in AGM and liver cell
suspensions from 10, 11, and 12 dpc embryos.As shownstained with c-kit-specific antibody or isotype-matched
control. As shown in Figures 1A and 1C, three sorting in Figure 2, increases in the percentages of c-kit1 cells
are found at 11 dpc in both AGM and liver when com-regions were set according to the relative levels of c-kit
surface expression: c-kit1 (R1), c-kitlo (R2), and c-kit2 pared with 10 dpc. However, at 12 dpc the percentages
decrease in both tissues, but remain higher than at 10(R3). The c-kit1 populations of both the AGM region and
liver appear to contain cells mainly with high forward dpc. To determine whether these changes were re-
flected in the functional characteristics of these c-kit1scatter, indicating that they are large in size. Side scatter
analysis shows that all populations of AGM cells are populations, we performed reconstitution experiments
(Table 3). Peripheral blood DNA of each of the recipientshighly granular (with the c-kit1 population most granular)
compared with liver. Varying numbers of cells from each was examined by PCR for the presence of the donor
LacZ transgene. When considering the number of em-of the c-kit-sorted regions were transferred into un-
marked irradiated recipient mice and donor cell en- bryo equivalents, the reconstitution potential of liver
c-kit1 cells at 11 dpc is similar to the AGM c-kit1 cells,graftment was measured at 1 month and more than 5
months posttransplantation. Recipient peripheral blood although 10 times more liver c-kit1 cells are required.
At 12 dpc, the liver c-kit1 population appears to containDNA was analyzed by polymerase chain reaction (PCR)
for the presence of the donor LacZ transgene. As shown more abundant LTR-HSC activity than the AGM region.
As expected from the limited number of transplant recip-for one representative experiment in Figures 1B and 1D,
blood DNA samples from animals receiving c-kitlo and ients and previously published frequency data from un-
sorted cells (Mu¨ller et al., 1994), no repopulated recipi-c-kit2 cells from AGM or liver were negative (<1%) for
donor LacZ signal. Only when c-kit1 cells were trans- ents were observed with 10 dpc c-kit1 AGM or liver
cells. These datasuggest that LTR-HSC activity peaks inplanted did recipientsexhibit high level donor cell repop-
ulation. The cumulative results from several experi- the AGM region at 11 dpc, while this activity is increased
enormously in the liver at 12 dpc.ments, shown in Table 1, demonstrate that high level
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Figure 1. LTR-HSCs Are Localized in the c-kit1 Cell Population Obtained from 11 dpc AGM and Liver Embryonic Tissue
Cells suspensions from pooled AGM regions and livers from 11 dpc embryos were prepared as described in Experimental Procedures and
analyzed by two-color flow cytometry for the expression of the c-kit antigen on PI-negative gated cells. Dot plot representations of forward
light scatter (FSC) properties and surface c-kit expression on AGM (A) and liver cells (C) are shown. The cells included in each gate are
designated as c-kit1 (R1), c-kitlo (R2), and c-kit2 (R3) according to the relative intensity of expression of the c-kit antigen. The percentage of
cells stained with FITC-conjugated isotype control and FITC-conjugated c-kit MAb is indicated for representative experiments. Histogram
representations of the side scatter (SSC) properties for the cells included in each sorting region are also shown for the AGM (A) and liver (C).
The mean value of the percentage (range is indicated in parentheses) of cells included in each sorting region for the number of experiments
indicated in Table 1 is as follows: for the AGM, c-kit1 10% (7%–17%), c-kitlo 36% (30%–38%), and c-kit2 40% (35%–50%); for the liver, c-kit1
25% (19%–28%), c-kitlo 26% (20%–30%), and c-kit2 41% (38%–45%). Sorted cells were transferred to irradiated recipients and peripheral
blood DNA was examined by PCR analysis 6 months posttransplantation for the donor marker LacZ. Autoradiograms of Southern blots after
gel electrophoresis are shown from representative experiments: DNA samples from animals transplanted with the indicated numer of c-kit-
sorted AGM cells (B) and liver cells (D). Each lane shows the PCR amplification of blood DNA from an individual recipient. Contribution controls
indicate 100%, 10%, 1%, and 0% LacZ signal, with myogenin as the normalization standard. Quantitation was performed by phosphorimager,
and percentages of engraftment of the positive recipients are from 20% to 100% when 6 3 103 c-kit1 cells from the AGM are transferred and
70% to 90% when 60 3 103 c-kit1 cells from the liver are used.
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Table 1. LTR-HSC Activity of Cells Sorted from 11 dpc AGM and Liver
Donor Cells per Reconstituted
Number of Recipienta Recipients/Total
Tissue Cell Type Experiments (3 103) Recipientsb
AGM c-kit1 5 6.6 (2–14) 12 of 20
c-kitlo 5 8.2 (5–14) 0 of 12
4 41 (30–60) 1 of 13
c-kit2 4 8.5 (6–11) 0 of 12
2 54 (50–60) 0 of 6
Liver c-kit1 5 6 (3–11) 0 of 11
5 76 (57–90) 7 of 13
c-kitlo 4 6.2 (4–10) 0 of 10
4 87 (30–133) 0 of 9
c-kit2 3 7.6 (6–7) 0 of 7
4 145 (90–300) 0 of 9
The c-kit1, c-kitlo, and c-kit2 cells from both AGM and liver were sorted as indicated in Figure 1. Sorted cells were transferred into irradiated
recipients, and peripheral blood DNA was examined by PCR analysis for the donor marker LacZ as indicated in Figure 1.
a The mean number of injected cells per recipient is shown, and the range is indicated in parentheses.
b Analysis after 5–10 months posttransfer.
Comparative Characterization of c-kit1 However, as shown in Figure 3A, Mac-1 was present in
a significant fraction of c-kit1 cells in the AGM regionSubsets in 11 dpc AGM and Liver
c-kit has previously been shown to be expressed not (11%) and liver (22%). In both tissues, no significant
coexpression with c-kit was observed for the erythro-only in HSCs, but also in committed hematopoietic pro-
genitor cells and nonhematopoietic cells. Most notably, cyte-associated antigen Ter119 or Thy-1 (although Thy-
11 cells represent 14% of c-kit2 AGM cells). HSC-asso-it has been shown to be expressed on primordial germ
cells (PGCs) located in the genital ridges of the AGM ciated antigens Sca-1, AA4.1, CD34, and CD44 were
also analyzed. Sca-11 cells represent less than 1% ofregion. To determine whether AGM and liver c-kit1 cells
exhibited anycharacteristics of these other populations, the c-kit1 population in the AGM region and the liver.
However, 20% of AGM c-kit1 cells and 94% of liverwe examined lineage-specific surface antigens by flow
cytometry. Expression analysis of surface antigens as- c-kit1 cells express high levels of CD44. In contrast with
the liver, where most c-kit2 cells are CD441, the c-kit2sociated with differentiated hematopoietic lineages
showed no significant levels of CD2, B220, CD8, CD4, population of the AGM is mostly CD442. CD34, another
HSC-associated antigen, is expressed on 20% of c-kit1or Gr-1 on 11 dpc AGM or liver cells (data not shown).
Table 2. Multilineage Analysis of Recipient Animals Reconstituted with c-kit1 cells from 11 dpc AGM and Liver
Number of Animals with Donor Signal after 6–10 Months
Donor Same Pattern of Donor Signal
Cells Reconstitution after 1 Month (Bl) Bl Th S LN BM B MF
c-kit1 AGM
6 111 111 111 111 111 111 111 111
2 111 111 111 111 111 111 111 11
2 111 111 11 111 111 111 111 111
1 111 111 111 111 111 111 11 111
1 111 111 111 111 111 2 111 111
1 11 11 11 11 11 11 11 2
1 11 11 1 1 1 1 1 2
c-kit1 Liver
3 111 111 111 111 111 111 111 111
1 111 111 111 111 111 111 111 11
2 111 111 111 111 111 2 111 111
1 111 111 11 111 111 11 11 111
1 111 11 111 111 111 11 11 1
1 111 11 11 1 11 111 11 11
1 111 11 1 11 11 1 11 11
1 11 11 11 11 11 1 11 11
1 11 2 2 2 2 2 1 1
1 11 2 2 2 2 1 2 1
Genomic DNA samples from individual recipient tissues and 100%, 10%, 1%, and 0% diilutions of a LacZ genomic DNA control were
simultaneously subjected to LacZ and myogenin PCR amplification. Samples were separated by electrophoresis and photographed. Scoring
of ethidium bromide–stained gels is as follows: minus (no signal); plus (signal lower than the 10% but higher than 1% control); double plus
(signal lower than 100% but higher than 10% control); and triple plus (signal very strong, similar to 100%). In several experiments, semiquantita-
tive analysis of the donor signal was confirmed by blotting the PCR gels and filter hybridization with myogenin and LacZ radiolabeled probes.
Evaluation of reconstitution levels presented no significant variation with the scoring on ethidium bromide gels. B, B lymphocytes; Bl, blood;
BM, bone marrow; LN, lymph nodes; MF, macrophages; S, spleen; Th, thymus.
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Figure 2. Analysis of c-kit Expression in the AGM and Liver during Embryonic Development
Cell suspensions from the AGM and liver were obtained from pools of embryos at the indicated ages. The histogram of cells stained with
immunoglobulin isotype control (dotted line) is superimposed over the histogram of cells stained with anti-c-kit MAb-FITC (solid line). The
staining was simultaneously performed on the six tissues, and the percentage of positive cells refers to the cell fraction with the highest
intensity of c-kit expression relative to the values obtained on 11 dpc. All profiles shown are for PI-negative cells. Percentages of positive
cells in one representative experiment are shown. The mean values of percent c-kit1 cells (range shown in parentheses) obtained from three
or four experiments are 4.8% (3%–5%), 12.2% (10%–15%), and 10% (8%–14%) for 10, 11, and 12 dpc AGM cells, respectively, and 10%
(3%–20%), 36% (21%–40%), and 11.8% (10%–15%) for 10, 11, and 12 dpc liver cells, respectively.
AGM cells and on 37% of c-kit1 liver cells. Finally, AA4.1, antigens expressed in these two anatomically distinct
sites. However, there are some differences in the per-which is found on HSCs as well as pre-B cells, is ex-
pressed on 18% of c-kit1 AGM region cells and 8% of centage of LTR-HSCs found within these sites that may
be due to, first, the expansion of the c-kit1-committedc-kit1 liver cells.
Since c-kit is also expressed in PGCs, we analyzed progenitors within the liver, which decrease the overall
percentage of LTR-HSCs and/or, second, the cosortingthec-kit1 cellsof the AGM region and liver for expression
of the enzyme alkaline phosphatase (AP). Previously, AP of PGCs within the c-kit1 AGM population. Thus, the
specific tissue localization of c-kit1 cells within the em-has been used as a specific marker for PGCs (Merchant-
Larios et al., 1985). As shown in Figure 3B, cytospin bryo appears to be an important factor in the assess-
ment of LTR-HSC frequency and potential.preparations of AGM c-kit1-sorted cells showed 15%
AP1 cells (Figure 3B, 1) and 0% AP1 cells in the liver
c-kit1-sorted cells (Figure 3B, 2). In the AGM c-kitlo-
sorted population, 2%–3% AP1 cells were detected LTR-HSCs in Early- and Mid-Gestation
Embryos Are c-kit1CD341(data not shown).
In general, the comparative phenotypic characteriza- Previously CD34 has been used to enrich for LTR-HSCs
in the adult mouse bone marrow (Krause et al., 1994)tion of c-kit1-sorted cells from the AGM region and liver
shows no major differences between the hematopoietic and day 14 fetal liver (Zeigler et al., 1994). To determine
Table 3. Reconstitution with c-kit1 Cells from 10, 11, and 12 dpc AGM and Liver
Embryo Reconstituted
Cells per Recipient Equivalents per Recipients/Total
Embryo Age Tissue (3 103)a Recipient Recipients
Day 10 AGMb 5.7 (0.5–14) 2.8 (1.2–6) 0 of 18
Liverc 7.4 (7–12) 1.5 (1.2–1.5) 0 of 15
Day 11d AGM 8.4 (1.7–20) 3 (0.4–5) 18 of 32
Liver 60.5 (10–100) 3.3 (0.4–5) 13 of 27
Day 12e AGM 11.5 (5–28) 1.7 (0.7–4) 8 of 20
Liver 6 (5–7) 0.1 (0.1–0.2) 13 of 14
Reconstitution data were obtained 1 month posttransplantation. Positive recipients were identified by PCR amplification of the donor LacZ
signal from genomic DNA obtained from peripheral blood. Level of reconstitution was determined as indicated in Figure 1. Only recipients
with signal .10% are considered positive.
a The mean number of injected cells per recipient is shown, and the range is indicated in parentheses.
b Mean of four experiments. c-kit1 included c-kit1 and c-kitlo.
c Mean of three experiments.
d Mean of nine experiments.
e Mean of three experiments.
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Figure 3. Characterization of c-kit1 Cells from the AGM Region and
Liver of 11 dpc Mouse Embryos
(A) The cell surface expression of different antigens is represented
by FACS dot plot analysis. Cell suspensions from 11 dpc AGM and
fetal liver were stained with FITC-conjugated anti-c-kit and PE- or
biotin-conjugated MAbs against various leukocyte antigens. PI-pos-
itive cells are excluded from the analysis window. R1 andR2 indicate
the representative sorting windows used in Figure 1. The mean
values (range in parentheses) of several experiments (between two
and seven) for the percentage of total positive cells for each antigen
are as follows: in the AGM, CD44 7.1% (5%–11%), Ter119 6.5%
(0.6%–12%), Mac-1 2% (1.7%–7%), Thy1.2 13.9% (11%–17%), Sca-
1 1% (0.8%–1.3%), AA4.1 3% (2%–4%), and CD34 9% (5%–13%);
in the liver, CD44 73% (55%–90%), Ter119 13% (3.0%–33%), Mac-
1 7.9% (4%–12%), Thy1.2 1.1% (0.3%–1.6%), Sca-1 0.5% (0.3%–
0.9%), AA4.1 3.9% (3%–4%), and CD34 13% (7%–20%). The per-
centage of cells coexpressing c-kit and each antigen is as follows:
in the AGM,CD44 3.8% (2%–5%), Ter1190%, Mac-1 2.6% (1%–5%),
Thy1.2 0.5% (0.4%–1%), Sca-1 0.1% (0.05%–0.3%), AA4.1 1.4%
(1.3%–1.6%), and CD34 1.9% (1.6%–2.4%); in the liver, CD44 36%
(30%–56%) Ter119 0.5% (0%–2%), Mac-1 4% (2%–6.3%), Thy1.2
0.5% (0.2%–0.8%), Sca-1 0.3% (0.1%–0.7%), AA4.1 1.7% (1.2%–
2.2%), and CD34 8.4% (5.4%–11%).
(B) c-kit1 cells were sorted from the AGM region and liver according
to sorting windows indicated in Figure 1. After sorting, cytospin
preparations were stained for alkaline phosphatase (AP). In the rep-
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whether CD34 expression may discriminate a c-kit1 sub- ple staining was performed with c-kit-, CD34-, and Mac-
1-specific antibodies on 11 dpc AGM region and liverpopulation with LTR-HSC activity in the 11 dpc AGM
region and liver, we performed transplantation studies (Figure 4). Whereas most (76%) liver c-kit1CD341 cells
are Mac-11, a smaller fraction (54%) of AGM c-kit1with c-kit and CD34 stained and sorted cells. As shown
in Figure 3A, sorting gates were set for c-kit1CD341 (R1) CD341 cells are Mac-11. Transplantation experiments
were performed with cells from the Mac-11 and Mac-and c-kit1CD342 (R2) subpopulations from the AGM and
liver, and varying numbers of sorted cells were injected 12 sorting criteria shown in Figure 3A. Both AGM sub-
populations were found to contain LTR-HSCs (Table 4)into irradiated recipients. Peripheral blood DNA was an-
alyzed for the presence of the donor LacZ marker in in similar frequencies. As most reconstitution activity is
found in the c-kit1CD341 fraction, we could speculatethese recipients at 6–10 months posttransplantation.
The cumulative results of eight different experiments that the CD341 cells in the c-kit1Mac-12 population (Fig-
ure 4) are responsible for the reconstitution activity. Inwith 3 3 103 to 7 3 103 injected c-kit1CD341 AGM cells
yielded 8 of 26 (31%) recipient animals repopulated, contrast, most of the LTR-HSC activity in the 11 dpc
liver is found within the c-kit1CD341Mac-11 population.whereas only 1 of 24 (4%) recipients was reconstituted
with 3 3 103 to 10 3 103 injected c-kit1CD341 liver cells. These data are suggestive of Mac-1 as an ontogenic
marker in the maturation pathway of HSCs, as an adhe-If the number of c-kit1CD341 liver cells is increased to
15 3 103 to 100 3 103, 5 of 18 animals are reconstituted sion/homing molecule in determining the anatomical lo-
cation of HSCs in development, or both (Figure 5).(28%). No LTR-HSC activity was found in 18 recipients
transplanted with 3 3 103 to 10 3 103 c-kit1CD342-
sorted AGM cells. However, 2 of 9 and 1 of 27 recipients
Discussioninjected with approximately 10-fold more c-kit1CD342
AGM or liver cells, respectively, were donor cell en-
Phenotypic Characterization of LTR-HSCsgrafted and may represent contamination by CD341
in the AGM Region and Livercells or true repopulating potential by CD342 cells. Cell
We have previously shown that the AGM region is thelineage reconstitution experiments performed 6–8
first anatomical site within the mouse embryo wheremonths posttransplantation on 7 positive animals re-
HSCs with long-term repopulating activity appearceiving AGM c-kit1/CD341, 4 animals receiving liver
(Mu¨ller et al., 1994; Medvinsky and Dzierzak, 1996). Inc-kit1/CD341, and 1 animal receiving liver c-kit1/CD342
this report we show that early 11 dpc AGM region andcells demonstrated that all hematopoietic tissues and
liver LTR-HSCs bear similar surface markers to late fetallineages were donor cell derived. Levels of repopulation
liver and adult bone marrow LTR-HSCs. Consistent withof splenic B cells, peritoneal macrophages, blood, thy-
previous studies demonstrating the expression of c-kitmus, spleen, and lymph node were found to be 100%
on these fetal and adult cells (Zeigler et al., 1994;positive (data not shown) in 10 of the recipient animals
Morrison et al., 1995; Okada et al., 1991; Ikuta andanalyzed, with only 2 of them 10% repopulated in macro-
Weissman, 1992), we found all LTR-HSCs in the earlyphages and bone marrow. Thus, these studies demon-
and mid-gestation embryo to be c-kit1. In none of thestrate that LTR-HSC activity is found predominantly in
experiments performed were LTR-HSCs found in thethe c-kit1CD341 subpopulation at 11 dpc AGM and liver.
c-kit2 fraction, even when high numbers of c-kit2 cellsAt 12 dpc the same phenotypic characteristics are
were injected.observed (data not shown). CD34 is found on 60% of
We have also found some similarities between embryothe c-kit1 liver cells and the LTR-HSC activity was de-
and adult LTR-HSCs in the expression of the CD34 sur-tected only in the c-kit1CD341 population (103 cells were
face marker. In agreement with previous studies onrequired to yield 4 of 8 recipients repopulated). None of
CD34 expression on human (Berenson et al., 1988, 1991;the 11 recipients transplanted with 10 3 103 to 30 3 103
Andrews et al., 1992; Baum et al., 1992) and murinec-kit1CD342 cells was reconstituted. Thus, LTR-HSCs
HSCs and progenitors (Zeigler et al., 1994; Krause etare more enriched in 12 dpc c-kit1CD341-sorted liver
al., 1994), we found the majority of LTR-HSCs in the 11cells than in the comparable 11 dpc sorted population.
dpc AGM region and 11, 12, and 13 dpc liver (data notThese data suggest that organism developmental time is
shown) to be CD341. However, we cannot exclude thea critical factor in the assessment of LTR-HSC potential
possibility that a small proportion of LTR-HSCs do notwithin this phenotypically defined population.
express the CD34 marker, since 2 of 9 recipient animals
injected with high numbers (42 3 103 to 50 3 103) CD342Some but Not All c-kit1CD341 AGM LTR-HSCs
AGM cells and 1 of 27 recipients injected with 25 3 103Are Mac-11
to 300 3 103 CD342 liver cells were reconstituted. TheseTo determine whether a distinctive embryonic marker
results are consistent with a recent report showing thatcould be found on AGM and early fetal liver LTR-HSCs,
the CD342c-kit1Lin2 fraction of cells from bone marrowwe examined such cells for the expression of Mac-1.
has reconstituting potential (Osawa et al., 1996). How-Previously it has been shown that in the 13 dpc liver all
ever, in the same work it was shown that the CD341LTR-HSCs are Mac-11 (Morrison et al., 1995). Thus, tri-
c-kit1Lin2 bone marrow fraction does not contain LTR-
HSCs. Thus, some phenotypic variation may occur be-
tween embryo and adult LTR-HSCs, as has been shown
for CD48RB, major histocompatibility complex class I,resentative experiment shown, approximately 15% of the c-kit1 cells
and Mac-1 antigens (Rebel et al., 1996; Huang and Auer-from the AGM region are AP1 (1). Cells with similar AP staining
intensity are not found in c-kit1 fetal liver (2). bach, 1993; Morrison et al., 1995). Alternatively, the
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Figure 4. Expression of Mac-1 on c-kit1CD341 Cells
Triple staining was performed with FITC-c-kit, PE-Mac-1, and biotin-CD34 MAbs followed by the addition of streptavidin red 670. Coexpression
of CD34 and Mac-1 is represented for the total and the c-kit1-gated population of the AGM and liver cells obtained from 11 dpc embryos. PI
staining was not performed on these cells, and thus some dead cells may be represented in the FACS plots.
ACK2 anti-c-kit MAb (Ogawa et al., 1991, 1993; Broudy while about 200 3 103 unsorted 11 dpc liver cells yield
59% of recipients reconstituted (Mu¨ller et al., 1994), 75 3et al., 1996) used by Osawa et al. (1996) may have a
preferential blocking effect on the long-term repopulat- 103 c-kit1 liver cells were required for 43% of recipients
to be reconstituted. When considering the number ofing activity of the CD341 bone marrow cells.
In addition, further support for similarities between embryo equivalents transferred in these experiments, it
appears that some AGM LTR-HSCs (at least 50%) areembryo and adult LTR-HSCs comes from preliminary
experiments using Sca-1-sorted cells. While Huang and lost in the sorting procedure. This may be due to the
sensitivity of these embryonic cells to the antibody orAuerbach (1993) were unable to detect Sca-1 on the
surface of cells with LTR-HSC activity in the 11 dpc YS, the physical constraints (time or temperature) of sorting
embryonic cells.we have found that the small Sca-11c-kit1 fraction in the
11 dpc AGM region has LTR-HSC activity (unpublished Using antibodies against the CD34 and Mac-1 mark-
ers on 11 dpc AGM region and liver c-kit1 cells, we weredata). Consistent with this, we have recently shown that
a LacZ transgene under the transcriptional regulatory unable to achieve any further enrichment. The lack of
additional enrichment may be due to the need for bothelements of the Ly-6E.1 (Sca-1) gene is expressed highly
in the 11 dpc AGM region (specifically in the anterior positive and negative populations to be simultaneously
transferred for efficient seeding of the adult environ-pro-mesonephros) but not in the YS (Miles et al., 1997).
ment. Alternatively, it is possible that a blocking effect
of the antibodies against CD34 and Mac-1 (both areEnrichment of LTR-HSCs within the Mouse Embryo
Previously our laboratory has demonstrated that the adhesion molecules) inhibits the repopulation potential.
Supporting this hypothesis are results of four trans-transplantation of 60 3 103 cells from one unsorted AGM
region enables 57% of recipient mice to be highly recon- plantation experiments performed with triple stained
and sorted CD34/Mac-1/c-kit AGM cells in which westituted (Mu¨ller et al., 1994). We show here that only 6 3
103 c-kit1 AGM cells are required for 60% of recipients found no donor-positive animals. Only when sorted cells
were obtained from 12–13 dpc liver were we able findto be highly reconstituted. Thus, in terms of absolute
cell number, the isolation of c-kit1 cells enabled us to repopulation (unpublished data). Although not yetexam-
ined for LTR-HSCs, the role of Mac-1 in adhesion hasenrich for AGM region LTR-HSCs by a factor of 10. In
contrast, 11 dpc liver LTR-HSCs were enriched only been clearly shown in human neutrophils, where Mac-
1-specific MAbs specifically block attachment and mi-3-fold and required many more cells for reconstitution;
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Table 4. Characterization of c-kit1 Cells with Long-Term Reconstitution Activity Obtained from 11 dpc Embryonic AGM Region and
Liver
Donor Cells per Reconstituted
Number of Recipienta Recipients/Total
Tissue Cell Type Experiments (3 103) Recipientsb
AGM c-kit1CD341 8 4.5 (3–7) 8 of 26
c-kit1CD342 8 6.4 (3–10) 0 of 27
3 46 (42–50) 2 of 9
Liver c-kit1CD341 8 7.1 (3–10) 1 of 24
8 50 (15–100) 5 of 18
c-kit1CD342 8 6.6 (3–10) 0 of 18
8 94 (25–300) 1 of 27
AGM c-kit1Mac-11 5 4.1 (3–5) 3 of 17
c-kit1Mac-12 4 4.5 (4–5) 2 of 13
3 28 (18–33) 4 of 10
Liver c-kit1Mac-11 4 5 (4–7.5) 1 of 14
3 21 (15–30) 4 of 8
c-kit1Mac-12 4 5 (4–5) 0 of 10
7 80 (33–150) 1 of 19
Cells were stained with FITC-conjugated anti-c-kit and biotin-conjugated anti-CD34 or with FITC-conjugated anti-c-kit and PE-conjugated
anti-Mac-1 and sorted according to the regions indicated in Figure 3: c-kit1CD341 versus c-kit1CD342 or c-kit1Mac-11 versus c-kit1Mac-12.
Each sorted subset was intravenously injected into irradiated recipient mice. Evaluation of reconstitution is described in Figure 1 and
Experimental Procedures.
a The mean number of injected cells per recipient is shown, and the range is indicated in parentheses.
b Analysis 6–12 months posttransplantation.
gration across surface adherent platelets (Diacovo et Developmental Expression of HSC Markers
on Other Embryonic Cellsal., 1996; Pytela, 1988; Corbi et al., 1988; Zeger et al.,
1990). Similarly, thymocytes from human CD34 trans- During embryogenesis LTR-HSCs appear later (10 dpc)
than the cell surface antigens associated with them, andgenic mice specifically adhere to human bone marrow
cells (Healy et al., 1995), and this interaction is depen- it is well documented that cells other than hematopoietic
cells express these surface antigens. For example, his-dent upon CD34 glycosylation. Thus, developmental
changes on CD34 and Mac-1 molecules may account tologic analysis has shown that CD34 is expressed in the
endothelium of blood vessels in early embryos (Young etfor the escape of 12–13 dpc fetal liver cells from putative
antibody blocking effects. It will be interesting to deter- al., 1995) and that c-kit is expressed in the migrating
PGCs and neuronal cells (Matsui et al., 1990; Keshet etmine whether we can obtain further enrichment of AGM
and early liver LTR-HSCs with antibodies against other al., 1991). Similarly, during early embryogenesis (7.5–10
dpc) other cells resembling hematopoietic progenitorsmarkers.
Figure 5. Spatial and Temporal Phenotypic Characterization of LTR-HSCS in the Mouse Embryo
Populations of cells from 11 dpc AGM region and 11 and 12 dpc liver characterized for surface expression of c-kit, CD34, and Mac-1 and for
functional LTR-HSC activity are indicated in this schematic drawing. Broken arrows indicate possible maturation/migration pathways. At 11
dpc, liver LTR-HSC activity is low (low) as compared with LTR-HSC activity in 12 dpc liver (high).
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express c-kit or CD34 (Young et al., 1995; Palacios and transplants. Also within the AGM region, the c-kit1
CD341 population can be subdivided into Mac-11 andNishikawa, 1992). Although the functional hematopoietic
properties of these cells has not been addressed, they Mac-12 fractions, both containing LTR-HSCs. Cells from
the AGM region colonize the liver, possibly at any of thecould be committedprogenitors. This would be in accor-
stages described. However, it is interesting to speculatedance with the fact that committed progenitors in the
that c-kit1 cells expressing the CD34 and Mac-1 (andbone marrow express c-kit and CD34 and also with the
possibly other) adhesion molecules preferentially seedabsence of LTR-HSCs in the YS until 11 dpc. In addition,
the liver, since most liver LTR-HSCs are found in thethis population of cells may contain hematopoietic cells
CD341Mac-11 fraction. In addition to its function ascapable of multipotent in vitro differentiation but not
an adhesion molecule, Mac-1 may be related to theLTR-HSC activity (Godin et al., 1995).
proliferation of these cells, as has been previously sug-The expression of c-kit on PGCs in the 11 dpc AGM
gested (Morrison et al., 1994). Cell cycle analysis wouldregion adds further heterogeneity to this population. We
help to elucidate the quiescent versus the proliferatinghave shown that a small percentage of c-kit1 cells in
cell status depending on the Mac-1 expression.the AGM region are positive for the AP marker, while
At 11 dpc, only a minor fraction of c-kit1CD341Mac-c-kit1 cells from the liver are AP2. This is of someinterest
11 liver cells are LTR-HSCs. This may be a result ofin the development of LTR-HSCs, since it has recently
rapid expansion or inflow (or both) from the YS of hema-been suggested that PGCs may play a role in the genera-
topoietic progenitors bearing the same phenotypiction of the definitive adult hematopoietic system (Rich,
markers (Moore and Metcalf, 1970; Medvinsky et al.,1995). We are presently examining whether the c-kit1/
1996). One day later, the differentiation of these cellsCD341 double positive population from 11 dpc AGM
may be reflected in the increase (3–5 times from 11 dpcregion contains AP1 cells.
to 12 dpc) in c-kit2 liver hematopoietic cells, most of
which are erythroid Ter1191 cells (data not shown;
Ogawa et al., 1993). By 12 dpc, the c-kit1CD341Mac-Temporal and Spatial Distribution of LTR-HSCs
11 liver fraction contains 5–10 times more LTR-HSCin the Mouse Embryo
activity than at 11 dpc. This increase in activity mayThe data presented here indicate that during develop-
depend on the AGM region microenvironment, as a 15-ment both localization and temporal factors are essen-
fold increase in LTR-HSC activity has been found intial to the phenotypic characterization and functional
10–11 dpc AGM organ cultures (Medvinsky and Dzier-description of HSCs. As there is no single marker that
zak, 1996). Alternatively, the liver may also provide ancan uniquely identify HSCs within a population of cells,
environment for the expansion of LTR-HSCs, as thesewe have shown that a panel of known markers are ex-
cells increase in liver until 15 dpc (the AGM region de-pressed on LTR-HSCs during ontogeny. The differential
generates by 13 dpc). This work thus provides a tempo-display of these cell surface markers may indicate rela-
ral and spatial phenotypic basis from which the specifictionships between HSCs at the distinct anatomical sites
LTR-HSC defects in mutant mice affected in definitiveduring development. In the mouse embryo, the AGM
hematopoiesis can be examined during development.region is the first tissue to autonomously generate LTR-
In conclusion, thephenotypic characterization of LTR-HSCs (Mu¨ller et al., 1994; Medvinsky and Dzierzak,
HSCs in the AGM region and liver of the developing1996). Subsequently, the liver harbors LTR-HSC activity
mouse embryo suggests that these cells are directlywhich increases during mid-gestation. The sequential
related to the definitive HSCs of the late fetal liver andappearance of LTR-HSCs in these tissues along with
adult bone marrow. The differential expression of Mac-1phylogenetic data in nonmammalian vertebrates (Die-
suggests a development pathway for maturation or lo-terlen-Lie`vre and Le Douarin, 1993; Medvinsky, 1993;
calization (or both) of LTR-HSCs. We are presently per-Dzierzak and Medvinsky, 1995) strongly suggests the
forming further characterization of these first HSCs tocolonization of the liver by LTR-HSCs generated in the
reveal distinct markers and, more importantly, uniqueAGM region. In combination with our phenotypic, fre-
molecules that function in the induction and expansionquency, and functional data, a model for the spatial and
of these cells during development.temporal relationships among LTR-HSCs is suggested
in Figure 5.
Experimental ProceduresIn the AGM region, LTR-HSCs are found predomi-
nantly in the c-kit1CD341 population. These cells may Cell Preparation
arise from the c-kit1CD342 fraction, also found in the For the generation of embryos, (CBA 3 C57BL/10)F1 females were
bred with Ly-6E.1 LacZ transgenic homozygous males (Miles et al.,AGM region. The recently described AGM organ culture
1997). The appearance of the vaginal plug was designated as daythat generates and increases LTR-HSC activity (Medvin-
0. Embryos were removed and embryonic tissues (AGM region andsky and Dzierzak,1996) will be very useful in determining
liver) were dissected as previously described (Mu¨ller et al., 1994).
whether these cellsor possibly the AA4.11 multipotential Cell suspensions were obtained by incubation of embryonic tissues
para-aortic splanchnopleural cells described by Godin at 378C for 1 hr in 0.04% collagenase (Sigma) in L-15 medium (Flow
et al. (1995) are such pre-LTR-HSCs. Alternatively, we Lab) supplemented with fetal calf serum (5%–10%), followed by
gentle mechanical dispersion. Viable cells were counted using try-could transfer the pre-LTR-HSCs directly into the em-
pan blue dye exclusion.bryo. YS-derived cells from 8–9 dpc embryos have been
shown to reconstitute some hematolymphoid lineages
Fluorescent Antibody Surface Staining
if injected into embryonic or neonatal recipients (Weiss- and Flow Cytometry
man et al., 1978; Toles et al., 1989; Yoder et al., 1995), The antibodies used in flow cytometric sorting and analysis were
all obtained from Pharmingen (San Diego, CA) except for AA4.1overcoming a possible limitation of embryo-to-adult
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(a gift from Dr. A. Mu¨ller, Frieberg). The MAbs used were direct spleen, lymph nodes, blood, and thymus. B cells were either en-
riched by sorting B2201 cells from bone marrow or spleen or by aconjugates with either fluorescein isothiocyanate (FITC), phycoer-
ythrin (PE), or biotin. Antibodies used in this study include the follow- spleen cell suspension culture stimulated with 10mg/ml lipopolysac-
charide (Sigma) for 7 days. Macrophages were either enriched foring: FITC-anti-c-kit (3C1), PE-anti-CD2 (RM2-5), PE-anti-CD4 (RM4-
5), PE-anti-CD8 (53-6.7), PE-anti-Mac-1 (M1/70), PE-anti-CD44 Mac-11 cells from bone marrow or spleen or as an adherent cell
fraction from the peritoneum followed by expansion in culture with(IM7), PE-anti-B220 (RA3-GB2), PE-anti-Gr-1 (RB6-8C5), PE-anti-
Thy 1.2 (53-2.1), PE-anti-Sca-1 (E13-161.7), PE-anti-Ter119, biotinyl- 10% L929 conditioned medium for 4–10 days.
All animals were obtained from the National Institute for Medicalated anti-CD34 (RAM34), and biotinylated AA4.1. Single cell suspen-
sions from AGM and liver were prepared as previously described Research animal facilities, and all animal procedures were in accor-
dance with the Animal Scientific Procedures Act, 1986 (United(Mu¨ller et al., 1994). Cells were suspended in L-15 medium with 5%
FCS. Incubation with CD16/CD32 (2.462) MAb was performed for Kingdom).
20 min on ice to lower nonspecific staining, followed by incubation
with specific MAbs for 20–30 min on ice. Cells were washed twice Acknowledgments
and incubated with PE-conjugated streptavidin (Pharmingen) or red
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